AstraZeneca's experimental drug Baxdrostat succeeds in hypertension trial, meeting all primary and secondary endpoints and showing a favorable safety profile.
Manchester City sign Norwegian prodigy Sverre Nypan, plan loan move to aid his development.
AstraZeneca's experimental drug Baxdrostat succeeds in hypertension trial, meeting all primary and secondary endpoints and showing a favorable safety profile.
Manchester City sign Norwegian prodigy Sverre Nypan, plan loan move to aid his development.